Trials / Completed
CompletedNCT03159507
Effect of Omega-3 Index on Cellular Metabolism and Quality of Life
Effect of Omega-3 Index on Cellular Metabolism and Quality of Life Following the Administration of a Customized Dose of Omega-3 Oil
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- SCF Pharma · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Determine whether personal optimization of the Omega-3 index improves cellular metabolism and quality of life (according to the SF-36 form).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MAG-EPA | Based on the result of the participant's Omega-3 index obtained from the blood sampling of visit 1, the daily dose of MAG-EPA will be adjusted to obtain an Omega-3 Index of 8. |
Timeline
- Start date
- 2017-10-02
- Primary completion
- 2019-03-14
- Completion
- 2019-03-14
- First posted
- 2017-05-18
- Last updated
- 2019-04-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03159507. Inclusion in this directory is not an endorsement.